CRO Selection & Management | The ABRA PROOF™ Method
More on how this works in practice: Common questions about CRO selection
CRO Selection and Management
The right CRO partner. The right operating model. From the start.
Choosing a CRO is one of the most consequential decisions a biotech or emerging biopharma company makes. It shapes timelines, budgets, data quality and, often, the next funding milestone. Many capable sponsors make this decision without dedicated clinical outsourcing expertise on staff.
ABRA Clinical Consulting brings that expertise to your side of the table. Founder and Managing Principal Angela Brady has spent over 25 years in clinical research, including senior leadership roles at ICON, IQVIA, Thermo Fisher Scientific and Allucent. She understands how proposals are built, how delivery teams are staffed and how contract terms shape performance after signature. Today she applies that experience exclusively on behalf of sponsors.
That experience is built into a structured, white-glove process: the ABRA PROOF™ Method.
A Selection Decision You Can Stand Behind
When your board or investors ask why you chose your CRO, you should be able to show them a clear, documented rationale.
In our experience, selection challenges rarely come from choosing an incapable CRO. They come from factors that are hard to see during a typical bid process:
Team continuity. The team presenting at bid defense may not be the team assigned to your study.
Budget comparability. Differences in units, assumptions and pass-through costs mean the lowest headline bid is not always the lowest total cost.
Open assumptions. Items left undefined in a proposal often return later as change orders.
Fit. Reputation is important, but phase, indication, geography and account size are better predictors of a strong partnership.
The ABRA PROOF™ Method is designed to address each of these factors in a structured, transparent way.
The ABRA PROOF™ Method
Five stages. Five signed proof points. Contract-ready by the end of Week 12.
Each stage ends with a documented deliverable, a proof point that you review and approve before the next stage begins.
P — Position the Program
Weeks 1–2 · About 4 hours of sponsor time
We define what the right CRO looks like for your study before any CRO sees it.
R — Right-size the Field
Weeks 2–3 · About 2 hours of sponsor time
We invite only the CROs best positioned to succeed on your program.
O — Orchestrate the Bid
Weeks 4–7 · About 8–10 hours of sponsor time, mostly bid defenses
We make every proposal comparable and every commitment verifiable.
O — Optimize the Award
Weeks 8–12 · About 4 hours of sponsor time
We translate the selected proposal into contract terms that reflect what was offered.
F — Fortify the Start
Contract-readiness through day 90 after signature · About 1 hour per checkpoint, plus your legal counsel during negotiation
We carry the agreed terms into the signed contract, then stay with you so the CRO delivers what it proposed.
The Outcome Ledger
At contract-readiness, every sponsor receives a one-page Outcome Ledger documenting what the engagement delivered.
A White-Glove Engagement
You make the decisions. ABRA manages the process.
Engagement Options
All PROOF™ engagements are fixed-fee and paid on milestones.
PROOF Essentials (Stages P and R): signed selection criteria and a documented shortlist
PROOF Complete (Stages P through Optimize): a contract-ready award, with every gap between proposal, budget, and your needs closed
PROOF Complete + Fortify (all five stages): a contract-ready award, negotiation support through signature, a governance framework, and a 90-day health report.
Our timeline commitment: if a proof point within ABRA's control is delivered late, the next milestone invoice is reduced by 10%.
Beyond Selection: Ongoing CRO Oversight
For sponsors who need continued support after the first 90 days, ABRA also provides:
Ongoing CRO oversight and performance management: metrics review, governance meetings and senior-level relationship management
Inspection and audit readiness: making sure your sponsor oversight documentation meets regulatory expectations
Fractional clinical operations leadership for teams building internal capability
Who We Work With
ABRA partners with biotech and emerging biopharma companies that have strong science and lean clinical operations teams, including:
Early-stage companies preparing their first outsourced clinical study
Growth-stage sponsors selecting a CRO for a new phase or program
Sponsors reassessing an existing CRO relationship
Start with the Clinical Trial Readiness Check
Selecting a CRO in the next six months? The Clinical Trial Readiness Check shows where your program stands and where PROOF™ should begin.